---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-015396"
form_type: "8-K"
ticker: "TDOC"
cik: "0001477449"
company_name: "Teladoc Health, Inc."
filed_at: "2022-10-26T23:59:59+00:00"
generated_at: "2026-06-23T00:47:15.381961+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Teladoc Health Q3 revenue up 17% to $611.4M; net loss narrows to $73.5M

## Summary
- Q3 revenue $611.4M (+17% YoY); net loss $73.5M ($0.45/sh) vs $84.3M loss prior year.
- Adjusted EBITDA $51.2M, above high end of guidance; operating cash flow $63.0M.
- Nine-month 2022 net loss $9.85B driven by non-cash goodwill impairment; revenue $1.77B (+20%).
- CEO Jason Gorevic cited strong quarter and progress on whole-person care strategy.

## SEC filing metadata
- accession: 0001558370-22-015396
- form_type: 8-K
- ticker: TDOC
- cik: 0001477449
- company_name: Teladoc Health, Inc.
- filed_at: 2022-10-26T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1477449/000155837022015396/0001558370-22-015396-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1477449/000155837022015396/tdoc-20221026x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-015396
- JSON: https://secwatch.observer/filing/0001558370-22-015396.json
- Plain text: https://secwatch.observer/filing/0001558370-22-015396.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.